世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

医療用神経リハビリテーション管理ソフトウェアの世界市場成長(現状と展望)2024-2030年


Global Medical Neurorehabilitation Management Software Market Growth (Status and Outlook) 2024-2030

医療神経リハビリ管理ソフトウェアは、患者情報管理、リハビリ計画策定、リハビリ進捗追跡、データ分析・評価、医師と患者のコミュニケーションなど複数の機能を統合し、神経リハビリ機関、リハビリ療法士、患者... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2024年7月24日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
104 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

医療神経リハビリ管理ソフトウェアは、患者情報管理、リハビリ計画策定、リハビリ進捗追跡、データ分析・評価、医師と患者のコミュニケーションなど複数の機能を統合し、神経リハビリ機関、リハビリ療法士、患者にワンストップソリューションを提供します。ビッグデータや人工知能などの先進技術を駆使し、神経リハビリテーション・プロセスを精緻に管理することで、より良いリハビリテーション成果を実現する。
世界の医療用神経リハビリテーション管理ソフトウェア市場規模は、2024年の100万米ドルから2030年には100万米ドルに成長すると予測されており、2024年から2030年までの年平均成長率は%で推移すると予測されています。
LPI(エルピーアイ情報)の最新調査レポート「医療用神経リハビリテーション管理ソフトウェア産業予測」は、過去の売上高から2022年の世界の医療用神経リハビリテーション管理ソフトウェアの総売上高を検証し、2023年から2029年までの医療用神経リハビリテーション管理ソフトウェアの売上高予測について地域別・市場分野別に包括的な分析を提供します。医療用神経リハビリテーション管理ソフトウェアの売上高を地域別、市場分野別、サブセクター別に分類し、世界の医療用神経リハビリテーション管理ソフトウェア産業の詳細な分析を百万米ドル単位で提供します。
このインサイトレポートでは、世界の医療用神経リハビリテーション管理ソフトウェア業界を包括的に分析し、製品セグメンテーション、企業設立、収益、市場シェア、最新動向、M&A活動などに関する主要動向を明らかにします。また本レポートでは、医療用神経リハビリテーション管理ソフトウェアのポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡を中心に、世界の主要企業の戦略を分析し、加速する世界の医療用神経リハビリテーション管理ソフトウェア市場におけるこれらの企業の独自の地位をより深く理解していきます。
この調査レポートは、医療用神経リハビリテーション管理ソフトウェアの世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの定性的・定量的市場インプットに基づいた透明性の高い手法により、この調査予測は世界の医療用神経リハビリテーション管理ソフトウェアの現状と将来の軌道について非常にニュアンスのある見解を提供します。
医療用神経リハビリテーション管理ソフトウェアの米国市場は、2023年の100万米ドルから2030年までに100万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。
医療用神経リハビリテーション管理ソフトウェアの中国市場は、2023年の100万米ドルから2030年には100万米ドルに、2024年から2030年までの年平均成長率は%と推定される。
医療用神経リハビリテーション管理ソフトウェアのヨーロッパ市場は、2023年の100万米ドルから2030年には100万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。
医療用神経リハビリテーション管理ソフトウェアの世界的な主要企業は、Roche、Lifescan、Abbott、Ascensia、B. Braunなどです。収益面では、2023年に世界の大手2社がほぼ%のシェアを占めています。
この調査レポートは、医療用神経リハビリテーション管理ソフトウェア市場の製品タイプ、用途、主要企業、主要地域、国別の包括的な概要、市場シェア、成長機会を掲載しています。
タイプ別セグメント
従来型
インテリジェント
用途別セグメント
病院
クリニック
その他
本レポートは地域別にも市場を分割しています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
タイプ別セグメント
従来型
インテリジェント
用途別セグメント
病院
クリニック
その他
本レポートは地域別にも市場を分割しています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
ロシュ
ライフスキャン
アボット
アセンシア
B.ブラウン
テルモ
シノケア
アークレイ
GMMCグループ
ビオニメ
LIANFA
ロベックメディカルAG


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Neurorehabilitation Management Software Market Size 2019-2030
2.1.2 Medical Neurorehabilitation Management Software Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Medical Neurorehabilitation Management Software by Country/Region, 2019, 2023 & 2030
2.2 Medical Neurorehabilitation Management Software Segment by Type
2.2.1 Conventional
2.2.2 Intelligent
2.3 Medical Neurorehabilitation Management Software Market Size by Type
2.3.1 Medical Neurorehabilitation Management Software Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Medical Neurorehabilitation Management Software Market Size Market Share by Type (2019-2024)
2.4 Medical Neurorehabilitation Management Software Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Medical Neurorehabilitation Management Software Market Size by Application
2.5.1 Medical Neurorehabilitation Management Software Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Medical Neurorehabilitation Management Software Market Size Market Share by Application (2019-2024)
3 Medical Neurorehabilitation Management Software Market Size by Player
3.1 Medical Neurorehabilitation Management Software Market Size Market Share by Player
3.1.1 Global Medical Neurorehabilitation Management Software Revenue by Player (2019-2024)
3.1.2 Global Medical Neurorehabilitation Management Software Revenue Market Share by Player (2019-2024)
3.2 Global Medical Neurorehabilitation Management Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Medical Neurorehabilitation Management Software by Region
4.1 Medical Neurorehabilitation Management Software Market Size by Region (2019-2024)
4.2 Global Medical Neurorehabilitation Management Software Annual Revenue by Country/Region (2019-2024)
4.3 Americas Medical Neurorehabilitation Management Software Market Size Growth (2019-2024)
4.4 APAC Medical Neurorehabilitation Management Software Market Size Growth (2019-2024)
4.5 Europe Medical Neurorehabilitation Management Software Market Size Growth (2019-2024)
4.6 Middle East & Africa Medical Neurorehabilitation Management Software Market Size Growth (2019-2024)
5 Americas
5.1 Americas Medical Neurorehabilitation Management Software Market Size by Country (2019-2024)
5.2 Americas Medical Neurorehabilitation Management Software Market Size by Type (2019-2024)
5.3 Americas Medical Neurorehabilitation Management Software Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Neurorehabilitation Management Software Market Size by Region (2019-2024)
6.2 APAC Medical Neurorehabilitation Management Software Market Size by Type (2019-2024)
6.3 APAC Medical Neurorehabilitation Management Software Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Medical Neurorehabilitation Management Software Market Size by Country (2019-2024)
7.2 Europe Medical Neurorehabilitation Management Software Market Size by Type (2019-2024)
7.3 Europe Medical Neurorehabilitation Management Software Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Neurorehabilitation Management Software by Region (2019-2024)
8.2 Middle East & Africa Medical Neurorehabilitation Management Software Market Size by Type (2019-2024)
8.3 Middle East & Africa Medical Neurorehabilitation Management Software Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Medical Neurorehabilitation Management Software Market Forecast
10.1 Global Medical Neurorehabilitation Management Software Forecast by Region (2025-2030)
10.1.1 Global Medical Neurorehabilitation Management Software Forecast by Region (2025-2030)
10.1.2 Americas Medical Neurorehabilitation Management Software Forecast
10.1.3 APAC Medical Neurorehabilitation Management Software Forecast
10.1.4 Europe Medical Neurorehabilitation Management Software Forecast
10.1.5 Middle East & Africa Medical Neurorehabilitation Management Software Forecast
10.2 Americas Medical Neurorehabilitation Management Software Forecast by Country (2025-2030)
10.2.1 United States Market Medical Neurorehabilitation Management Software Forecast
10.2.2 Canada Market Medical Neurorehabilitation Management Software Forecast
10.2.3 Mexico Market Medical Neurorehabilitation Management Software Forecast
10.2.4 Brazil Market Medical Neurorehabilitation Management Software Forecast
10.3 APAC Medical Neurorehabilitation Management Software Forecast by Region (2025-2030)
10.3.1 China Medical Neurorehabilitation Management Software Market Forecast
10.3.2 Japan Market Medical Neurorehabilitation Management Software Forecast
10.3.3 Korea Market Medical Neurorehabilitation Management Software Forecast
10.3.4 Southeast Asia Market Medical Neurorehabilitation Management Software Forecast
10.3.5 India Market Medical Neurorehabilitation Management Software Forecast
10.3.6 Australia Market Medical Neurorehabilitation Management Software Forecast
10.4 Europe Medical Neurorehabilitation Management Software Forecast by Country (2025-2030)
10.4.1 Germany Market Medical Neurorehabilitation Management Software Forecast
10.4.2 France Market Medical Neurorehabilitation Management Software Forecast
10.4.3 UK Market Medical Neurorehabilitation Management Software Forecast
10.4.4 Italy Market Medical Neurorehabilitation Management Software Forecast
10.4.5 Russia Market Medical Neurorehabilitation Management Software Forecast
10.5 Middle East & Africa Medical Neurorehabilitation Management Software Forecast by Region (2025-2030)
10.5.1 Egypt Market Medical Neurorehabilitation Management Software Forecast
10.5.2 South Africa Market Medical Neurorehabilitation Management Software Forecast
10.5.3 Israel Market Medical Neurorehabilitation Management Software Forecast
10.5.4 Turkey Market Medical Neurorehabilitation Management Software Forecast
10.6 Global Medical Neurorehabilitation Management Software Forecast by Type (2025-2030)
10.7 Global Medical Neurorehabilitation Management Software Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Medical Neurorehabilitation Management Software Forecast
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Medical Neurorehabilitation Management Software Product Offered
11.1.3 Roche Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Lifescan
11.2.1 Lifescan Company Information
11.2.2 Lifescan Medical Neurorehabilitation Management Software Product Offered
11.2.3 Lifescan Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Lifescan Main Business Overview
11.2.5 Lifescan Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Medical Neurorehabilitation Management Software Product Offered
11.3.3 Abbott Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 Ascensia
11.4.1 Ascensia Company Information
11.4.2 Ascensia Medical Neurorehabilitation Management Software Product Offered
11.4.3 Ascensia Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Ascensia Main Business Overview
11.4.5 Ascensia Latest Developments
11.5 B. Braun
11.5.1 B. Braun Company Information
11.5.2 B. Braun Medical Neurorehabilitation Management Software Product Offered
11.5.3 B. Braun Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 B. Braun Main Business Overview
11.5.5 B. Braun Latest Developments
11.6 TERUMO
11.6.1 TERUMO Company Information
11.6.2 TERUMO Medical Neurorehabilitation Management Software Product Offered
11.6.3 TERUMO Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 TERUMO Main Business Overview
11.6.5 TERUMO Latest Developments
11.7 Sinocare
11.7.1 Sinocare Company Information
11.7.2 Sinocare Medical Neurorehabilitation Management Software Product Offered
11.7.3 Sinocare Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sinocare Main Business Overview
11.7.5 Sinocare Latest Developments
11.8 ARKRAY
11.8.1 ARKRAY Company Information
11.8.2 ARKRAY Medical Neurorehabilitation Management Software Product Offered
11.8.3 ARKRAY Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ARKRAY Main Business Overview
11.8.5 ARKRAY Latest Developments
11.9 GMMC Group
11.9.1 GMMC Group Company Information
11.9.2 GMMC Group Medical Neurorehabilitation Management Software Product Offered
11.9.3 GMMC Group Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 GMMC Group Main Business Overview
11.9.5 GMMC Group Latest Developments
11.10 BIONIME
11.10.1 BIONIME Company Information
11.10.2 BIONIME Medical Neurorehabilitation Management Software Product Offered
11.10.3 BIONIME Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 BIONIME Main Business Overview
11.10.5 BIONIME Latest Developments
11.11 LIANFA
11.11.1 LIANFA Company Information
11.11.2 LIANFA Medical Neurorehabilitation Management Software Product Offered
11.11.3 LIANFA Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 LIANFA Main Business Overview
11.11.5 LIANFA Latest Developments
11.12 Lobeck Medical AG
11.12.1 Lobeck Medical AG Company Information
11.12.2 Lobeck Medical AG Medical Neurorehabilitation Management Software Product Offered
11.12.3 Lobeck Medical AG Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Lobeck Medical AG Main Business Overview
11.12.5 Lobeck Medical AG Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

Medical neurorehabilitation management software integrates multiple functions such as patient information management, rehabilitation plan formulation, rehabilitation progress tracking, data analysis and evaluation, and doctor-patient communication, providing a one-stop solution for neurorehabilitation institutions, rehabilitation therapists, and patients. It uses advanced technologies such as big data and artificial intelligence to manage the neurorehabilitation process in a refined manner to achieve better rehabilitation results.
The global Medical Neurorehabilitation Management Software market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Medical Neurorehabilitation Management Software Industry Forecast” looks at past sales and reviews total world Medical Neurorehabilitation Management Software sales in 2022, providing a comprehensive analysis by region and market sector of projected Medical Neurorehabilitation Management Software sales for 2023 through 2029. With Medical Neurorehabilitation Management Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Neurorehabilitation Management Software industry.
This Insight Report provides a comprehensive analysis of the global Medical Neurorehabilitation Management Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Medical Neurorehabilitation Management Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Neurorehabilitation Management Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Neurorehabilitation Management Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Neurorehabilitation Management Software.
United States market for Medical Neurorehabilitation Management Software is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Medical Neurorehabilitation Management Software is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Medical Neurorehabilitation Management Software is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Medical Neurorehabilitation Management Software players cover Roche, Lifescan, Abbott, Ascensia, B. Braun, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Neurorehabilitation Management Software market by product type, application, key players and key regions and countries.
Segmentation by Type:
Conventional
Intelligent
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Conventional
Intelligent
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Lifescan
Abbott
Ascensia
B. Braun
TERUMO
Sinocare
ARKRAY
GMMC Group
BIONIME
LIANFA
Lobeck Medical AG



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Neurorehabilitation Management Software Market Size 2019-2030
2.1.2 Medical Neurorehabilitation Management Software Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Medical Neurorehabilitation Management Software by Country/Region, 2019, 2023 & 2030
2.2 Medical Neurorehabilitation Management Software Segment by Type
2.2.1 Conventional
2.2.2 Intelligent
2.3 Medical Neurorehabilitation Management Software Market Size by Type
2.3.1 Medical Neurorehabilitation Management Software Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Medical Neurorehabilitation Management Software Market Size Market Share by Type (2019-2024)
2.4 Medical Neurorehabilitation Management Software Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Medical Neurorehabilitation Management Software Market Size by Application
2.5.1 Medical Neurorehabilitation Management Software Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Medical Neurorehabilitation Management Software Market Size Market Share by Application (2019-2024)
3 Medical Neurorehabilitation Management Software Market Size by Player
3.1 Medical Neurorehabilitation Management Software Market Size Market Share by Player
3.1.1 Global Medical Neurorehabilitation Management Software Revenue by Player (2019-2024)
3.1.2 Global Medical Neurorehabilitation Management Software Revenue Market Share by Player (2019-2024)
3.2 Global Medical Neurorehabilitation Management Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Medical Neurorehabilitation Management Software by Region
4.1 Medical Neurorehabilitation Management Software Market Size by Region (2019-2024)
4.2 Global Medical Neurorehabilitation Management Software Annual Revenue by Country/Region (2019-2024)
4.3 Americas Medical Neurorehabilitation Management Software Market Size Growth (2019-2024)
4.4 APAC Medical Neurorehabilitation Management Software Market Size Growth (2019-2024)
4.5 Europe Medical Neurorehabilitation Management Software Market Size Growth (2019-2024)
4.6 Middle East & Africa Medical Neurorehabilitation Management Software Market Size Growth (2019-2024)
5 Americas
5.1 Americas Medical Neurorehabilitation Management Software Market Size by Country (2019-2024)
5.2 Americas Medical Neurorehabilitation Management Software Market Size by Type (2019-2024)
5.3 Americas Medical Neurorehabilitation Management Software Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Neurorehabilitation Management Software Market Size by Region (2019-2024)
6.2 APAC Medical Neurorehabilitation Management Software Market Size by Type (2019-2024)
6.3 APAC Medical Neurorehabilitation Management Software Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Medical Neurorehabilitation Management Software Market Size by Country (2019-2024)
7.2 Europe Medical Neurorehabilitation Management Software Market Size by Type (2019-2024)
7.3 Europe Medical Neurorehabilitation Management Software Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Neurorehabilitation Management Software by Region (2019-2024)
8.2 Middle East & Africa Medical Neurorehabilitation Management Software Market Size by Type (2019-2024)
8.3 Middle East & Africa Medical Neurorehabilitation Management Software Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Medical Neurorehabilitation Management Software Market Forecast
10.1 Global Medical Neurorehabilitation Management Software Forecast by Region (2025-2030)
10.1.1 Global Medical Neurorehabilitation Management Software Forecast by Region (2025-2030)
10.1.2 Americas Medical Neurorehabilitation Management Software Forecast
10.1.3 APAC Medical Neurorehabilitation Management Software Forecast
10.1.4 Europe Medical Neurorehabilitation Management Software Forecast
10.1.5 Middle East & Africa Medical Neurorehabilitation Management Software Forecast
10.2 Americas Medical Neurorehabilitation Management Software Forecast by Country (2025-2030)
10.2.1 United States Market Medical Neurorehabilitation Management Software Forecast
10.2.2 Canada Market Medical Neurorehabilitation Management Software Forecast
10.2.3 Mexico Market Medical Neurorehabilitation Management Software Forecast
10.2.4 Brazil Market Medical Neurorehabilitation Management Software Forecast
10.3 APAC Medical Neurorehabilitation Management Software Forecast by Region (2025-2030)
10.3.1 China Medical Neurorehabilitation Management Software Market Forecast
10.3.2 Japan Market Medical Neurorehabilitation Management Software Forecast
10.3.3 Korea Market Medical Neurorehabilitation Management Software Forecast
10.3.4 Southeast Asia Market Medical Neurorehabilitation Management Software Forecast
10.3.5 India Market Medical Neurorehabilitation Management Software Forecast
10.3.6 Australia Market Medical Neurorehabilitation Management Software Forecast
10.4 Europe Medical Neurorehabilitation Management Software Forecast by Country (2025-2030)
10.4.1 Germany Market Medical Neurorehabilitation Management Software Forecast
10.4.2 France Market Medical Neurorehabilitation Management Software Forecast
10.4.3 UK Market Medical Neurorehabilitation Management Software Forecast
10.4.4 Italy Market Medical Neurorehabilitation Management Software Forecast
10.4.5 Russia Market Medical Neurorehabilitation Management Software Forecast
10.5 Middle East & Africa Medical Neurorehabilitation Management Software Forecast by Region (2025-2030)
10.5.1 Egypt Market Medical Neurorehabilitation Management Software Forecast
10.5.2 South Africa Market Medical Neurorehabilitation Management Software Forecast
10.5.3 Israel Market Medical Neurorehabilitation Management Software Forecast
10.5.4 Turkey Market Medical Neurorehabilitation Management Software Forecast
10.6 Global Medical Neurorehabilitation Management Software Forecast by Type (2025-2030)
10.7 Global Medical Neurorehabilitation Management Software Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Medical Neurorehabilitation Management Software Forecast
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Medical Neurorehabilitation Management Software Product Offered
11.1.3 Roche Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Lifescan
11.2.1 Lifescan Company Information
11.2.2 Lifescan Medical Neurorehabilitation Management Software Product Offered
11.2.3 Lifescan Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Lifescan Main Business Overview
11.2.5 Lifescan Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Medical Neurorehabilitation Management Software Product Offered
11.3.3 Abbott Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 Ascensia
11.4.1 Ascensia Company Information
11.4.2 Ascensia Medical Neurorehabilitation Management Software Product Offered
11.4.3 Ascensia Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Ascensia Main Business Overview
11.4.5 Ascensia Latest Developments
11.5 B. Braun
11.5.1 B. Braun Company Information
11.5.2 B. Braun Medical Neurorehabilitation Management Software Product Offered
11.5.3 B. Braun Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 B. Braun Main Business Overview
11.5.5 B. Braun Latest Developments
11.6 TERUMO
11.6.1 TERUMO Company Information
11.6.2 TERUMO Medical Neurorehabilitation Management Software Product Offered
11.6.3 TERUMO Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 TERUMO Main Business Overview
11.6.5 TERUMO Latest Developments
11.7 Sinocare
11.7.1 Sinocare Company Information
11.7.2 Sinocare Medical Neurorehabilitation Management Software Product Offered
11.7.3 Sinocare Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Sinocare Main Business Overview
11.7.5 Sinocare Latest Developments
11.8 ARKRAY
11.8.1 ARKRAY Company Information
11.8.2 ARKRAY Medical Neurorehabilitation Management Software Product Offered
11.8.3 ARKRAY Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ARKRAY Main Business Overview
11.8.5 ARKRAY Latest Developments
11.9 GMMC Group
11.9.1 GMMC Group Company Information
11.9.2 GMMC Group Medical Neurorehabilitation Management Software Product Offered
11.9.3 GMMC Group Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 GMMC Group Main Business Overview
11.9.5 GMMC Group Latest Developments
11.10 BIONIME
11.10.1 BIONIME Company Information
11.10.2 BIONIME Medical Neurorehabilitation Management Software Product Offered
11.10.3 BIONIME Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 BIONIME Main Business Overview
11.10.5 BIONIME Latest Developments
11.11 LIANFA
11.11.1 LIANFA Company Information
11.11.2 LIANFA Medical Neurorehabilitation Management Software Product Offered
11.11.3 LIANFA Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 LIANFA Main Business Overview
11.11.5 LIANFA Latest Developments
11.12 Lobeck Medical AG
11.12.1 Lobeck Medical AG Company Information
11.12.2 Lobeck Medical AG Medical Neurorehabilitation Management Software Product Offered
11.12.3 Lobeck Medical AG Medical Neurorehabilitation Management Software Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Lobeck Medical AG Main Business Overview
11.12.5 Lobeck Medical AG Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23 10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る